print this page

Clinical Trials: Obstetrics and Gynecology


Proteomic Assessment of Preterm Risk (PAPR) (IRB# BH12-020)

(Obstetrics and gynecology)
  • Principal Investor
    Glenn Markenson, MD
  • Summary

    The purpose of this study is to develop a test for the prediction of preterm delivery. 

    • Preterm delivery is defined as birth of a baby before the 37th week of pregnancy
  • More Information

    Inclusion Criteria:

    • Aged 18 years or older
    • English or Spanish speaker
    • Pregnant with one baby
    • Plan to deliver at Baystate Medical Center

    Exclusion Criteria:

    • Known or suspected complication with the baby
  • Study Site Location
    Baystate Medical Center, 759 Chestnut Street
  • Contact
    413.794.1053